Results 171 to 180 of about 9,854 (235)

The Cytotoxicity of Epsilon Toxin from Clostridium perfringens on Lymphocytes Is Mediated by MAL Protein Expression. [PDF]

Mol Cell Biol, 2018
Blanch M, Dorca-Arévalo J, Not A, Cases M, Gómez de Aranda I, Martínez-Yélamos A, Martínez-Yélamos S, Solsona C, Blasi J.   +8 more
europepmc   +1 more source

Photolytic Hydrophosphination: Insights Into Catalyzed and Uncatalyzed Processes

Chemistry – A European Journal, EarlyView.
Catalyst‐free photolytic hydrophosphination is demonstrated for vinyl arenes and activated alkenes in polar protic (alcohol) solvents. These reactions appear to be closed‐shell, affirming that even ambient light can impact a reaction—a potentially broad influence on even mundane reactions.
Emma J. Finfer, Evelyn M. Kempf, Rory Waterman   +2 more
wiley   +1 more source

Clostridium perfringens epsilon toxin induces blood brain barrier permeability via caveolae-dependent transcytosis and requires expression of MAL. [PDF]

PLoS Pathog, 2019
Linden JR, Flores C, Schmidt EF, Uzal FA, Michel AO, Valenzuela M, Dobrow S, Vartanian T.   +7 more
europepmc   +1 more source

Covalent Insertion of a Mn(Salen) Type Complex in Cross‐Linked Protein Crystals: Design of an Enantioselective Artificial Epoxidase

Chemistry – A European Journal, EarlyView.
An Artificial metalloenzyme was designed by a Michael addition between a MnSalen complex and a cysteine residue within NikA crystals. The heterogeneous catalyst was found capable of an enantioselective and stereospecific epoxidation of cis‐β‐methylstyrene in cristallo.
Manel Boukhallat, Ismail Benhamed, Jade Arnone, Stann Van Baaren, Clara Rinaldi, Patrice Catty, Caroline Marchi‐Delapierre, Christine Cavazza, Stéphane Ménage   +8 more
wiley   +1 more source

Research articleHemolysis in human erythrocytes by Clostridium perfringens epsilon toxin requires activation of P2 receptors. [PDF]

Virulence, 2018
Gao J, Xin W, Huang J, Ji B, Gao S, Chen L, Kang L, Yang H, Shen X, Zhao B, Wang J.   +10 more
europepmc   +1 more source

Valorization of Yacon (Smallanthus sonchifolius) peel for peroxidase production and its immobilization on alginate beads for 2,4‐dichlorophenol bioconversion

The Canadian Journal of Chemical Engineering, EarlyView.
Sodium alginate was modified with EDC/NHS for the immobilization of Yacon peel peroxidase, resulting in a novel biocatalyst for the oxidation of 2,4‐dichlorophenol. Abstract Yacon (Smallanthus sonchifolius) roots are emerging as an alternative source of peroxidase. This study aimed to extract, immobilize, and characterize the peroxidase from Yacon peel,
Mariana Gomes Oliveira, Marcela Pires Spaolonzi, Carla Ivane Ganz Vogel, Aniela Pinto Kempka, Everton Skoronski   +4 more
wiley   +1 more source

A Novel Panel of Rabbit Monoclonal Antibodies and Their Diverse Applications Including Inhibition of Clostridium perfringens Epsilon Toxin Oligomerization. [PDF]

Antibodies (Basel), 2018
Linden JR, Telesford K, Shetty S, Winokour P, Haigh S, Cahir-McFarland E, Antognetti G, Datta A, Wang T, Meier W, Vartanian T.   +10 more
europepmc   +1 more source

Green and sustainable synthesis of magnetite from copper slag via citrate complexation for methylene blue dye removal from water

The Canadian Journal of Chemical Engineering, EarlyView.
Abstract This study proposes a novel, green, and sustainable method for synthesizing magnetic iron oxides from metallurgical copper slag (CS), leveraging its iron content as a valuable resource. Iron was extracted via acid leaching using edible citric acid (ECA), forming a citrate–iron complex (CSL), which was subsequently thermally decomposed at 300°C
Melisa Portilla‐Sangabriel, Karen Valencia García, Tania‐Ariadna García‐Mejía, Agileo Hernández‐Gordillo, Rosa‐María Ramírez‐Zamora   +4 more
wiley   +1 more source

Bemnifosbuvir: An HCV NS5B Inhibitor With Multiple Modes of Action

Clinical Pharmacology &Therapeutics, EarlyView.
Bemnifosbuvir (BEM) is a potent, pan‐genotypic inhibitor targeting the hepatitis C virus (HCV) NS5B polymerase. Its antiviral activity was evaluated in an ascending dose phase I clinical trial involving 30 patients treated once a day for 7 days. After treatment initiation, plasma HCV RNA declined in a biphasic manner with a mean reduction of 2.3 log10 ...
Carolin Zitzmann, Ruy M. Ribeiro, Aurélien Marc, Xiao‐Jian Zhou, Alan S. Perelson   +4 more
wiley   +1 more source

Mapping of the continuous epitopes displayed on the Clostridium perfringens type D epsilon-toxin. [PDF]

Braz J Microbiol, 2017
Alves GG, Machado-de-Ávila RA, Chávez-Olórtegui CD, Silva ROS, Lobato FCF.   +4 more
europepmc   +1 more source